Training program: Clinical and Translational (C/T) Research Academy Program dates: July 2022 – May 2024 Application deadline: January 28, 2022 Two-year program offering advanced training in clinical and translational (c/t) investigation and a mentored research experience to clinicians and PhD researchers in Harvard-based clinical fellowships. This program focuses on clinical trial and study design, computational/statistical sciences, epidemiology, … Continue reading "Training program: Clinical and Translational (C/T) Research Academy"
Are you interested in learning more about refugee and migration rights? The FXB Center for Health and Human Rights at Harvard University, in collaboration with the National and Kapodistrian University of Athens, Greece, and with the support of the Harvard Center for Hellenic Studies in Greece and the U.S, is offering a three-week intensive, interdisciplinary, … Continue reading "Apply Now: Intensive Summer Course on Migration and Refugee Studies in Greece"
Abstract: Decision modeling has played a critical role in managing COVID-19 since the beginning of the pandemic. This talk will highlight the work done by the COVID-19 Modeling Consortium that … Continue reading "CHDS Seminar with Dr. Jagpreet Chhatwal: COVID-19 Policy Modeling: Past, Present, and Future"
Event Description Developed in the 1970s and commercialized shortly thereafter, Magnetic Resonance Imaging (MRI) has since become a mainstay diagnostic tool in practices ranging from oncology and orthopedics to neurology and cardiology. Traditional, fixed MRI machines are expensive and immobile. To limit costs and improve access for patients, companies began offering MRIs at stand-alone centers. … Continue reading "Challenges for Mobile Diagnostics: Mobile MRI as a Case Study"
The Dana-Farber/Harvard Cancer Center (DF/HCC) is delighted to announce Dr. Ann Partridge as our Keynote Speaker for the 2022 Celebration of Early Career Investigators in Cancer Research Symposium. Enjoy her talk followed by a panel discussion, oral presentations, and poster session. This symposium will showcase the talent of early career investigators at the DF/HCC who … Continue reading "DF/HCC Celebration of Early Career Investigators"
The Dana-Farber/Harvard Cancer Center (DF/HCC) is delighted to announce Dr. Ann Partridge as our Keynote Speaker for the 2022 Celebration of Early Career Investigators in Cancer Research Symposium. Enjoy her talk entitled "Improving Care and Outcomes for Young Women with Breast Cancer: From Observation to Intervention" followed by a panel discussion, oral presentations, and poster … Continue reading "DF/HCC Celebration of Early Career Investigators"
Ongoing global Covid-19 vaccine and therapeutic inequities threaten to prolong and exacerbate the pandemic for all countries. As advocates, academics, and policymakers alike call for the U.S. and other wealthy nations to share these lifesaving resources with the world, it is prudent to consider the lessons learned from the HIV pandemic that can be translated … Continue reading "Global Equity During Pandemics: Designing a New Paradigm"
Live Online Q&A with William Hanage, Associate Professor of Epidemiology, Harvard T.H. Chan School of Public Health. The Omicron surge is driving COVID-19 infections to historic highs, with more than … Continue reading "Combatting the Omicron Surge: Latest Updates"
Research Data Management (RDM) is essential for responsible research and planning should begin early. Your well-organized and documented data will meet funding agency requirements, be preserved, discoverable and reproducible. This in-person session will dive into recommended practices for managing research data and provide resources to help you apply those practices efficiently. Instructors: Julie Goldman, Research Data … Continue reading "In-person Seminar: Managing Research Data Efficiently"
Department of Epidemiology Seminar Series Open to the public. Speaker: Steven Goodman, MD, MHS, PhD Professor of Epidemiology and Population Health and of Medicine (Primary Care and Population Health) Associate … Continue reading "Regulatory Memory Loss: The FDA’s Road to Aducanumab"